Trasylol (aprotinin), manufactured by Bayer, is a medication used to treat excessive bleeding and inflammation in patients undergoing coronary artery bypass grafting surgery (CABG). Due to nature of CABG procedures, most people do not realize they received the drug until after the surgery is over, if ever. That practice however is slowly changing as the FDA and the New England Journal of Medicine have recently linked Trasylol to renal failure, heart attacks, and strokes. For those who have endured the CABG procedure, and subsequently suffered from a heart attack, stroke, and/or renal failure, these findings may come as a complete shock to the unwary patient. To understand more about the effects of Trasylol contact one of personal injury attorneys.
@thumbnail.jpg "M. Brandon Smith")
A partner with Childers, Schlueter & Smith, LLC,, Brandon Smith has devoted his practice to pharmaceutical litigation, mass torts, products liability and serious personal injury. A frequent guest speaker at legal seminars all over the country—Brandon is focused on helping injured victims nationwide, however possible. Named a SuperLawyer again in 2019, he has also been called out as one of 10 Best Attorneys For Georgia by the American Institute Of Personal Injury Attorneys and a Top 100 Lawyer in Georgia by the National Trial Lawyers in 2019.
Comments for this article are closed.